Skip to main content

Table 3 Retail percent mark-ups on one adult equivalent treatment dose (%)

From: Determinants of price setting decisions on anti-malarial drugs at retail shops in Cambodia

Anti-malarial categories formulation

Retailer categories

All N = 382

Pharmacies/ Clinical pharmacies N = 77

Drug stores N = 75

Mobile providers N = 101

Grocery stores N = 57

Village shops N = 72

ACT

(n)

(418)

(119)

(85)

(103)

(51)

(59)

all were tablets

Median

42.8

40.0

50.0

50.0

40.0

28.6

IQR

20.0–75.0

20.0–80.0

25.0–106.9

25.0–66.7

20.0–60.0

14.3–55.6

AMT

(n)

(177)

(32)

(37)

(46)

(29)

(33)

All

Median

37.1

16.7

29.2

42.9

33.3

60.0

 

IQR

20.0–66.7

7.1–42.9

16.7–55.5

25.0–71.4

20.0–41.2

42.9–84.6

AMT

(n)

(121)

(13)

(28)

(26)

(25)

(29)

Tablet

Median

37.1

15.4

37.1

33.3

33.3

60.0

 

IQR

20.0–71.4

7.7–25.9

16.7–90.5

25.0–66.7

20.0–41.2

37.1–87.5

AMT

(n)

(56)

(19)

(9)

(20)

(4)

(4)

Injectable

Median

40.0

28.0

29.0

50.0

38.5

47.1

 

IQR

19.0–55.6

7.1–42.9

16.7–41.2

25.0–77.8

20.0–42.9

42.9–66.7

nAMT

(n)

(84)

(18)

(16)

(22)

(13)

(15)

All

Median

100.0

53.8

100.0

127.3

177.8

100.0

 

IQR

50.0–185.7

7.1–100.0

66.7–150.0

50.0–185.7

33.3–185.7

66.7–150.0

nAMT

(n)

(64)

(18)

(13)

(10)

(10)

(13)

Tablet

Median

100.0

53.8

100.0

100.0

185.7

366.7

 

IQR

50–185.7

7.1–100.0

66.7–115.5

80–233.3

33.3–185.7

66.7–366.7

nAMT

(n)

(20)

-

(3)

(12)

(3)

(2)

Injectable

Median

166.7

-

191.7

150.0

33.3

366.7

 

IQR

50.0–200.0

-

191.7–275.0

50.0–185.7

17.6–177.8

66.7–366.7

  1. ACT is artemisinin combination therapy; AMT is artemisinin monotherapy; nAMT is non-artemisinin monotherapy; (n) is number of product observations; N is number of retailers for whom information was available; IQR is inter-quartile range. “-“drug category not stocked